Investing1d
La FDA accepte la demande supplémentaire de nouveau médicament d'Agios pour le traitement de la thalassémie PYRUKYND
La FDA accepte la demande supplémentaire de nouveau médicament d'Agios pour le traitement de la thalassémie PYRUKYND ...
AGIOS PHARMACEUTICALS, INC. : BofA Securities favorable sur le dossier
BofA Securities est positif et recommande le titre à l'achat. L'objectif de cours est abaissé de 60 USD à 55 USD.
Investing3d
La FDA approuve une mise à jour de l'étiquette de PYRUKYND d'Agios
Agios Pharmaceuticals, Inc. (NASDAQ:AGIO), une société biopharmaceutique, a annoncé lundi que la Food and Drug Administration (FDA) américaine a approuvé une mise à jour des informations de ...
Politico Europe22d
France’s Le Pen: Macron is ‘done’
PARIS — French far-right leader Marine Le Pen said Wednesday she’s getting ready to run for an early presidential election, predicting that Emmanuel Macron’s era as French president will be over ...
Reuters23d
French far-right leader Marine Le Pen eyes early presidential election
PARIS, Dec 18 (Reuters) - French far-right leader Marine Le Pen said on Wednesday that she was preparing for an early presidential election, saying President Emmanuel Macron's time in office was ...
Politico Europe29d
Is Le Pen about to blow up France?
PARIS — Marine Le Pen has always walked a tightrope between being the outsider, intent on taking a wrecking ball to the French establishment, and cultivating a more mainstream image to win ...